Published in Am Heart J on November 01, 1991
Lyme carditis--diagnosis, treatment and prognosis. Dtsch Arztebl Int (2015) 0.81
Lyme carditis: a United Kingdom perspective. Br Heart J (1993) 0.80
Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy. Med Microbiol Immunol (2010) 0.80
Cardiac conduction abnormalities in a mouse model of Lyme borreliosis. J Interv Card Electrophysiol (2001) 0.77
Suspected inflammatory cardiomyopathy. Prevalence of Borrelia burgdorferi in endomyocardial biopsies with positive serological evidence. Herz (2014) 0.76
Complete heart block in a 9 year old girl caused by borreliosis. Br Heart J (1993) 0.75
Electrocardiographic findings in children with erythema migrans. Wien Klin Wochenschr (2006) 0.75
Lyme carditis with complete heart block: management with an external pacemaker. Clin Case Rep (2017) 0.75
Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob Agents Chemother (1992) 3.09
Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest (1993) 2.58
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine (2013) 2.25
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol (1996) 1.70
Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med (2001) 1.69
Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. J Viral Hepat (2009) 1.69
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation (1999) 1.67
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Euro Surveill (2015) 1.50
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. J Viral Hepat (2008) 1.45
No association between hepatitis C and B-cell lymphoma. Hepatology (1999) 1.28
Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology (1999) 1.26
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut (2006) 1.22
Approaches to the detection of enteric pathogens, including Campylobacter, using nucleic acid hybridization. Diagn Microbiol Infect Dis (1986) 1.18
Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill (2013) 1.18
Assessment of in-flight transmission of SARS--results of contact tracing, Canada. Can Commun Dis Rep (2003) 1.11
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther (2006) 1.07
Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J Clin Microbiol (1995) 1.07
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents. J Viral Hepat (2011) 1.02
Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. Euro Surveill (2014) 1.00
A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol (2000) 0.99
Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis (2001) 0.97
Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. Gene Ther (1999) 0.95
Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factors and attributable mortality. J Infect Dis (1996) 0.95
Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study. Br J Cancer (2012) 0.95
Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy. J Viral Hepat (2005) 0.93
Evaluation of the Merifluor immunofluorescent assay for the detection of Cryptosporidium and Giardia in sodium acetate formalin-fixed stools. Diagn Microbiol Infect Dis (1994) 0.91
Self-collection of genital human papillomavirus specimens in heterosexual men. Sex Transm Infect (2008) 0.91
Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsia. BJOG (2010) 0.90
High-performance liquid chromatography to assess the effect of serum storage conditions on the detection of hepatitis C virus by the polymerase chain reaction. J Virol Methods (1993) 0.90
A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation (1996) 0.89
Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis (1993) 0.88
Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation. J Am Soc Nephrol (1998) 0.86
Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat (2009) 0.86
Polymerase chain reaction kinetics when using a positive internal control target to quantitatively detect cytomegalovirus target sequences. J Virol Methods (1994) 0.84
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin. Aliment Pharmacol Ther (2008) 0.83
Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013. Euro Surveill (2013) 0.83
Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest (2000) 0.82
Detection of hepatitis C virus in the corneas of seropositive donors. Cornea (2001) 0.81
Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance. Exp Hematol (1998) 0.81
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy. Can J Gastroenterol (2009) 0.81
Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada. Vaccine (2012) 0.79
Hepatitis A virus seroprevalence in 1,000 university students in Toronto. Can Commun Dis Rep (2001) 0.79
Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation. Transplantation (1999) 0.79
Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C. J Viral Hepat (1999) 0.79
Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest (1998) 0.78
Quantification of polymerase chain reaction products in agarose gels with a fluorescent europium chelate as label and time-resolved fluorescence spectroscopy. Anal Chem (1993) 0.77
A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma. Hum Gene Ther (1997) 0.77
Long-term predictive value of a single cytomegalovirus (CMV) DNA PCR assay for CMV disease in human immunodeficiency virus-infected patients. J Clin Microbiol (1998) 0.77
Polymerase chain reaction based assessment of leukoreduction efficacy using a cytomegalovirus DNA transfected human T-cell line. J Clin Virol (1998) 0.76
Continuous flow perfusion of gentamicin with a scleral shell reduces bacterial colony counts in experimental Pseudomonas keratitis. J Ocul Pharmacol (1993) 0.76
Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation. Transplant Proc (1997) 0.76
Epidemiologic profile of a new H3N2 variant of influenza A mismatched to vaccine, 2003-2004 influenza season. Can Commun Dis Rep (2005) 0.76
Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia. Can J Public Health (2009) 0.76
Hepatitis. Can J Infect Dis (2001) 0.75
Continuous flow contact lens delivery of gentamicin to rabbit cornea and aqueous humor. J Ocul Pharmacol (1992) 0.75
Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B. Am J Gastroenterol (1998) 0.75
Long term follow-up of patients with chronic hepatitis C treated with interferon alpha. Can J Gastroenterol (2000) 0.75
Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population. J Hepatol (1999) 0.75